During the past decade, Rajaie Cardiovascular Medical and Research Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rajaie Cardiovascular Medical and Research Center" #1 sponsor was "Rajaie Cardiovascular Medical and Research Center" with 3 trials, followed by "Shahid Beheshti University" with 3 trials sponsored, "Javad Nasrollahzadeh" with 1 trials sponsored, "Manuel Monreal" with 1 trials sponsored and "Modarres Hospital" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rajaie Cardiovascular Medical and Research Center" #1 collaborator was "Abidi Pharmaceuticals" with 1 trials as a collaborator, "Clinical Evaluation Research Unit at Kingston General Hospital" with 1 trials as a collaborator, "National Institute for Medical research and Development (NIMAD)" with 1 trials as a collaborator and "Shahid Beheshti University of Medical Sciences" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Rajaie Cardiovascular Medical and Research Center" are "Cardiovascular Risk Factor" (2 trials), "Coronary Artery Disease" (2 trials), "Acute Coronary Syndrome" (1 trials), "Anticoagulant Adverse Reaction" (1 trials) and "Aortic Valve Calcification" (1 trials). Many other conditions were trialed in "Rajaie Cardiovascular Medical and Research Center" in a lesser frequency.

Most popular intervention types in "Rajaie Cardiovascular Medical and Research Center" are "Dietary Supplement" (4 trials), "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Conventional catheter-directed thrombolysis (CDT) with recombinant tissue plasminogen activator (rtPA)" (1 trials), "Enoxaparin" (1 trials), "Extra-Virgin Olive Oil" (1 trials), "Garlic" (1 trials) and "Infant formula" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rajaie Cardiovascular Medical and Research Center" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Rajaie Cardiovascular Medical and Research Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Rajaie Cardiovascular Medical and Research Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Rajaie Cardiovascular Medical and Research Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".